Why Shares of Ginkgo Bioworks Plunged Today
While the market's enthusiasm for synthetic biology specialist, Ginkgo Bioworks (NYSE: DNA), was undeniable yesterday, investors seem less interested today despite the company announcing some interesting news. The stock soared more than 20% yesterday; however, it gave back some of those gains in today's session.
Shares of Ginkgo Bioworks ended the day down 7.1%, slightly less steep than the intraday drop of 11.5%.
Source Fool.com